In summary, low circulating concentrations of leptin, increased fat oxidation and insulin resistance are associated with increased circulating concentrations of cortisol and interleukin-6 in weight-losing patients with pancreatic cancer. This evidence concerns the gene LEP and pancreatic neoplasm.